Lynn D. Kramer
Impact in
- Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research
- Epilepsy research and treatment
- Biological Psychiatry top 1%
Papers in
-
- Dementia and Cognitive Impairment Research 13
- Epilepsy research and treatment 11
-
- Statistical Methods in Clinical Trials 8
- Co-authors
- Shobha DhaddaChad J. SwansonLarisa ReydermanMichael C. IrizarryMichio KanekiyoRandall J. BatemanPaul AisenMarwan Sabbagh
- Journals
- Alzheimer s & Dementia (25 papers)Neurology (6 papers)Epilepsia (6 papers)Alzheimer s Research & Therapy (4 papers)Annals of Neurology (4 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Lynn D. Kramer
58 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Psychiatry and Mental health 2.1k
- Biological Psychiatry 305
- Physiology 2.4k
- Neurology 700
- Pharmacology 765
Countries citing papers authored by Lynn D. Kramer
This map shows the geographic impact of Lynn D. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn D. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn D. Kramer more than expected).
Fields of papers citing papers by Lynn D. Kramer
This network shows the impact of papers produced by Lynn D. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn D. Kramer. The network helps show where Lynn D. Kramer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lynn D. Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 21 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 1 | |
| 11 | Lecanemab in Early Alzheimer’s Disease Hit paper breakdown → | 2022 | 2741 |
| 12 | Lecanemab in patients with early Alzheimer’s disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study Hit paper breakdown → | 2022 | 185 |
| 13 | 2022 | 8 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 9 | |
| 16 | 1996 | 206 | |
| 17 | 1992 | 170 | |
| 18 | 1990 | 1 | |
| 19 | 1989 | 8 | |
| 20 | 1987 | 27 |
About Lynn D. Kramer
Lynn D. Kramer is a scholar working on Psychiatry and Mental health, Statistics and Probability, Physiology, Computational Theory and Mathematics and Cellular and Molecular Neuroscience, having authored 64 papers that have together received 5.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (27 papers), Dementia and Cognitive Impairment Research (13 papers), Computational Drug Discovery Methods (11 papers), Epilepsy research and treatment (11 papers), Pharmacological Effects and Toxicity Studies (10 papers), Statistical Methods in Clinical Trials (8 papers), Cholinesterase and Neurodegenerative Diseases (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). The work is most often cited by research in Psychiatry and Mental health (2.1k citations), Biological Psychiatry (305 citations), Physiology (2.4k citations), Neurology (700 citations) and Pharmacology (765 citations). Lynn D. Kramer has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Shobha Dhadda, Chad J. Swanson, Larisa Reyderman, Michael C. Irizarry, Michio Kanekiyo, Randall J. Bateman, Paul Aisen, Marwan Sabbagh, Michelle Gee and Christopher H. van Dyck. Their work appears in journals such as Alzheimer s & Dementia, Neurology, Epilepsia, Alzheimer s Research & Therapy and Annals of Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.